AKT1 and hepatocellular carcinoma: The compensatory activation of these signaling pathways is in keeping with the significance of c-MET and PI3K-Akt-Tor signaling in the pathogenesis of HCC recently highlighted by extensive genetic investigation of this tumor15,16.